Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Metacrine, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 5 | 0 | −5 |
| Shares | 9.29M | 0 | −9.29M (−100.0%) |
| Value | $5.30M | $0 | −$5.30M (−100.0%) |
New holders (0)
Institutions that held Metacrine, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (5)
Institutions that held Metacrine, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| BML Capital Management, LLC | 6,167,458 | $3.52M |
| JBF Capital, Inc. | 1,945,270 | $1.11M |
| Artal Group S.A. | 924,898 | $528.0K |
| Tudor Investment Corp Et Al | 239,100 | $136.0K |
| Wedbush Securities Inc | 12,700 | $7.00K |